MedTrace Logo

National Register of Oesophageal Atresia

NCT02883725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1460

Last updated 2026-05-05

No results posted yet for this study

Summary

The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...).

The current prognosis for this ailment is good. However he persists a mortality (\<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) .

The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France.

The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.

Conditions

  • Esophageal Atresia

Interventions

OTHER

data collection

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Frédéric Gottrand, MD, PhD · University Hospital, Lille

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2016-12-31
Completion
2019-12-31

Countries

  • France
  • Guadeloupe
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883725 on ClinicalTrials.gov